Categories: News

Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2020 Financial Results and Conference Call

MINNEAPOLIS, MN / ACCESSWIRE / February 1, 2021 / Celcuity Inc. (NASDAQ:CELC), a clinical stage biotechnology company translating discoveries of new cancer sub-types into pioneering diagnostics and expanded therapeutic options for cancer patients, announced that it will release its financial results for the fourth quarter and fiscal year 2020 after the stock market close on Tuesday, February 16, 2021. Management will host a teleconference the same day at 4:30 p.m. Eastern Time (ET) to discuss the results.

Conference Call Details

Participants should dial 1-866-831-8616 and use passcode 92066. Participants are asked to dial in 5 to 10 minutes prior to the start of the call.

About Celcuity

Celcuity is a clinical stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity’s proprietary CELsignia diagnostic platform analyzes living tumor cells to untangle the complexity of the cellular activity driving a patient’s cancer. This allows Celcuity to discover new cancer sub-types molecular diagnostics cannot detect. We are driven to improve outcomes for patients and to transform how pharmaceutical companies define the patient populations for their targeted therapies. Celcuity is headquartered in Minneapolis, MN. Further information about Celcuity can be found at www.celcuity.com.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including the anticipated benefits to the clinical outcomes of cancer patients. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Celcuity, which include, but are not limited to, those set forth in the Risk Factors section of Celcuity’s Annual Report on Form 10-K for the year ended December 31, 2019. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Celcuity undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contacts:

Celcuity Inc.
Brian Sullivan, bsullivan@celcuity.com
Vicky Hahne, vhahne@celcuity.com

SOURCE: Celcuity Inc.

View source version on accesswire.com:
https://www.accesswire.com/627100/Celcuity-Inc-Schedules-Release-of-Fourth-Quarter-and-Fiscal-Year-2020-Financial-Results-and-Conference-Call

Staff

Recent Posts

Masimo Provides Facts in Response to Politan’s False Narrative

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today issued the following statement to set the record straight…

1 hour ago

CAREIUM & CSL EXTEND THEIR PARTNERSHIP WITH THE LAUNCH OF rSIM® TECHNOLOGY

Innovation Leaders in Technology-Enabled Care, Careium, and Critical Connectivity Experts, CSL, have announced the extension…

1 hour ago

Dagfinn Hallseth of NEO Consulting Receives Prestigious Recognition in 2024 Business Worldwide Magazine CEO Awards

Dagfinn Hallseth, CEO and founder of NEO Consulting AS, has been awarded the title of…

1 hour ago

Independent Cradle-to-Gate life cycle assessment shows AMSilk’s fibers have a significantly lower environmental footprint compared to silk

NEURIED, Germany, June 20, 2024 /PRNewswire/ -- AMSilk GmbH ("AMSilk"), a frontrunner in advanced biomaterials…

1 hour ago

Lupus Research Alliance Awards Lupus Insight Prize to Two Trailblazers in CAR T Cell Therapy

Drs. Marko Radic and Georg Schett Honored at FOCIS 2024 Meeting SAN FRANCISCO, June 20,…

1 hour ago

Ping An Receives Five “All-Asia Executive Team 2024” Accolades From Institutional Investor Magazine

HONG KONG and SHANGHAI, June 20, 2024 /PRNewswire/ -- Institutional Investor magazine has announced the…

1 hour ago